Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-12-09 6:22 pm Purchase | 13G | Verrica Pharmaceuticals Inc. VRCA | PERCEPTIVE ADVISORS LLC | 7,962,147 8.700% | 862,965 (+12.16%) | View |
| 2024-11-26 4:15 pm Purchase | 13D | Verrica Pharmaceuticals Inc. VRCA | Manning Paul B | 52,504,049 49.900% | 37,114,568 (+241.17%) | View |
| 2024-11-14 09:32 am Sale | 13G | Verrica Pharmaceuticals Inc. VRCA | Avoro Capital Advisors LLC | 0 0.000% | -6,583,332 (Position Closed) | View |
| 2024-02-14 4:47 pm Purchase | 13G | Verrica Pharmaceuticals Inc. VRCA | PERCEPTIVE ADVISORS LLC | 7,099,182 16.900% | 2,060,199 (+40.89%) | View |
| 2024-02-14 09:10 am Purchase | 13G | Verrica Pharmaceuticals Inc. VRCA | Avoro Capital Advisors LLC | 6,583,332 9.990% | 6,583,332 (New Position) | View |
| 2023-02-14 2:37 pm Purchase | 13G | Verrica Pharmaceuticals Inc. VRCA | PERCEPTIVE ADVISORS LLC | 5,038,983 12.300% | 1,428,571 (+39.57%) | View |
| 2022-07-15 4:15 pm Purchase | 13D | Verrica Pharmaceuticals Inc. VRCA | Manning Paul B | 15,389,481 37.400% | 4,761,904 (+44.81%) | View |
| 2022-02-14 4:37 pm Purchase | 13G | Verrica Pharmaceuticals Inc. VRCA | Manning Paul B | 10,627,577 38.600% | 789,830 (+8.03%) | View |
| 2022-02-14 3:54 pm Purchase | 13G | Verrica Pharmaceuticals Inc. VRCA | PERCEPTIVE ADVISORS LLC | 3,610,412 13.100% | 200,000 (+5.86%) | View |
| 2022-02-11 4:57 pm Unchanged | 13G | Verrica Pharmaceuticals Inc. VRCA | ORBIMED ADVISORS LLC | 0 0.000% | 0 (Unchanged) | View |
| 2022-01-27 11:04 am Sale | 13G | Verrica Pharmaceuticals Inc. VRCA | Davidson Matt | 560,731 2.040% | -884,272 (-61.20%) | View |
| 2021-02-16 8:57 pm Purchase | 13G | Verrica Pharmaceuticals Inc. VRCA | PERCEPTIVE ADVISORS LLC | 3,410,412 13.200% | 3,410,412 (New Position) | View |
| 2021-02-16 4:04 pm Purchase | 13G | Verrica Pharmaceuticals Inc. VRCA | Manning Paul B | 9,837,747 38.000% | 194,500 (+2.02%) | View |
| 2021-02-16 3:47 pm Sale | 13G | Verrica Pharmaceuticals Inc. VRCA | PERCEPTIVE ADVISORS LLC | 0 0.000% | -3,410,412 (Position Closed) | View |
| 2021-01-25 5:13 pm Sale | 13G | Verrica Pharmaceuticals Inc. VRCA | Davidson Matt | 1,445,003 5.600% | -1,028,157 (-41.57%) | View |
| 2020-02-14 4:39 pm Unchanged | 13G | Verrica Pharmaceuticals Inc. VRCA | PERCEPTIVE ADVISORS LLC | 3,410,412 13.200% | 0 (Unchanged) | View |
| 2020-01-31 6:41 pm Purchase | 13G | Verrica Pharmaceuticals Inc. VRCA | Manning Paul B | 9,643,247 37.400% | 68,386 (+0.71%) | View |
| 2020-01-30 4:15 pm Sale | 13G | Verrica Pharmaceuticals Inc. VRCA | Davidson Matt | 2,473,160 9.600% | -609,009 (-19.76%) | View |